octagam 50 mg/ ml
octapharma (2) - immunglobulin, normalt (humant) - infusjonsvæske, oppløsning - 50 mg/ ml
panzyga 100 mg/ ml
octapharma ab - immunglobulin, normalt, humant - infusjonsvæske, oppløsning - 100 mg/ ml
thymoglobuline 25 mg
sanofi b.v. - immunglobulin anti-human thymocytt (kanin) - pulver til infusjonsvæske, oppløsning - 25 mg
cuvitru 200 mg/ ml
baxalta innovations gmbh - immunglobulin, normalt, humant - injeksjonsvæske, oppløsning - 200 mg/ ml
hepatect 50 ie/ ml
biotest pharma gmbh - immunglobulin mot hepatitt b, humant - infusjonsvæske, oppløsning - 50 ie/ ml
rhesonativ 625 ie/ ml
octapharma as - immunglobulin anti-d, humant - injeksjonsvæske, oppløsning - 625 ie/ ml
umanbig 180 ie/ ml
kedrion s.p.a. - immunglobulin mot hepatitt b, humant - injeksjonsvæske, oppløsning - 180 ie/ ml
atgam 50 mg/ ml
pfizer as - immunglobulin anti-t-lymfocytt, animalsk, til human bruk - konsentrat til infusjonsvæske, oppløsning - 50 mg/ ml
flebogamma dif (previously flebogammadif)
instituto grifols s.a. - humant normalt immunglobulin - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - immune sera og immunglobuliner, - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.
hizentra
csl behring gmbh - human normal immunoglobulin (scig) - immunologiske mangelsyndrom - immune sera og immunglobuliner, - replacement therapy in adults, children and adolescents (0-18 years) in:- primary immunodeficiency syndromes with impaired antibody production (see section 4. - secondary immunodeficiencies (sid) in patients who suffer from severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure (psaf)* or serum igg level of.